Evidence map›Paper›PMID 40843444›Full record

ReviewFrontiers in bioengineering and biotechnology2025

Engineering copper and copper-based materials for a post-antibiotic era.

Yingxian Wang, Tongqiang Wen, Fuchao Mao, Shaozhe Yang, Qingwei Zhang, Xiuhong Fu, Chongkai Zhai, Hewei Zhang

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Biochemical Modulation of FeChemistry & biodiversity · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. A broad-spectrum inhibitor of copper-exporting PProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Surface Oxide Film and Antibacterial Activity of Zirconium-Based Bulk Metallic Glasses.Langmuir : the ACS journal of surfaces and colloids · 2026
    Article
  11. Article
  12. Article
  13. A First-In-Class Broad Spectrum Inhibitor of Copper Exporting PbioRxiv : the preprint server for biology · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yingxian WangSchool of Mechanical and Electrical Engineering, Luoyang Polytechnic, Luoyang, Henan, China.
Tongqiang WenSchool of Mechanical and Electrical Engineering, Luoyang Polytechnic, Luoyang, Henan, China.
Fuchao MaoCollege of Food and Drugs, Luoyang Polytechnic, Luoyang, Henan, China.
Shaozhe YangHenan Luohe Central Hospital, Luohe, Henan, China.
Qingwei ZhangHenan Luohe Central Hospital, Luohe, Henan, China.
Xiuhong FuHenan Luohe Central Hospital, Luohe, Henan, China.
Chongkai ZhaiCollege of Food and Drugs, Luoyang Polytechnic, Luoyang, Henan, China.
Hewei ZhangCollege of Food and Drugs, Luoyang Polytechnic, Luoyang, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the emergence of multidrug-resistant bacteria and the frequent outbreaks of novel viral pathogens have intensified the demand for novel, efficient, and low-toxicity antimicrobial materials. Copper and copper-based materials, owing to their broad-spectrum and potent antimicrobial properties, have attracted increasing attention across diverse fields, including medicine, agriculture, and environmental science. This review provides a comprehensive overview of the development history, antimicrobial and antiviral mechanisms, fabrication techniques, and bioactive characteristics of copper and its derivatives. It further highlights their current applications in healthcare, public infrastructure, food processing, textiles, and modern agriculture. Challenges associated with material stability, cytotoxicity and environmental safety, are critically discussed. Finally, future perspectives are proposed, emphasizing advances in material synthesis, the development of stable nano-coatings, controlled release strategies, low-toxicity and low-resistance formulations, establishment of standardized pharmacological and toxicological evaluation systems, drug delivery applications, and copper pollution control. This review aims to inform future efforts in overcoming the current limitations of copper-based antimicrobials and supporting their potential future integration into applications across medicine, public health, environmental protection, and agricultural innovation, contingent upon resolving current translational and regulatory challenges.

Indexed as

antimicrobial activityapplicationscopper-based materialsnanotechnologysurface engineering

Identifiers

PMID40843444
PMCPMC12364917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.